首页> 外文期刊>Drugs of today: Medicamentos de actualidad >A REPORT FROM THE 74(TH) AMERICAN DIABETES ASSOCIATION SCIENTIFIC SESSIONS (MAY 13-17-SAN FRANCISCO, CALIFORNIA, USA)
【24h】

A REPORT FROM THE 74(TH) AMERICAN DIABETES ASSOCIATION SCIENTIFIC SESSIONS (MAY 13-17-SAN FRANCISCO, CALIFORNIA, USA)

机译:74(Th)美国糖尿病协会科学会议的报告(5月13日至17日至13日 - 旧金山,美国,美国)

获取原文
获取原文并翻译 | 示例
           

摘要

The Moscone convention center became small this year for the sheer number of scientists and doctors attending the 74th American Diabetes Association Scientific Sessions, where hundreds of oral presentations and thousands of poster presentations discussing novel research findings related with diabetes, obesity, fatty liver disease and other diabetic-associated medical conditions were presented and discussed by attendees coming from all over the world. A significant number of presentations were related to experimental and investigational therapeutic candidates that are expected to bring new hope for the life of an increasing number of subjects acquiring diabetes worldwide, a phenomenon related to aging and lifestyles that has proved remarkably resistant to the current management strategies, including drug therapies and lifestyle recommendations. Some of these are summarized in the following report.
机译:今年莫斯通会议中心为纯粹的科学家和医生参加第74届美国糖尿病协会科学会议,其中数百个口腔介绍和数千个海报演示讨论了与糖尿病,肥胖,脂肪肝病和其他有关的新型研究结果 与来自世界各地的与会者提出和讨论了糖尿病相关的医疗条件。 大量的介绍与实验和调查治疗候选人有关,预计将为越来越多的患有全球糖尿病的受试者带来新的希望,这是与衰老和生活方式有关的现象,这已经证明了目前的管理策略显着抵制 ,包括药物治疗和生活方式建议。 其中一些总结在以下报告中。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号